Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Treatment and Management, and Cardiac pacing and defibrillation studies.
Heart Failure and Obesity: Translational Approaches and Therapeutic Perspectives. A Scientific Statement of the Heart Failure Association of the ESC
Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction
Adherence to Guideline-Directed Medical Treatments in Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy
Beta-blockers in Patients with Heart Failure with Reduced Ejection Fraction and Concomitant Chronic Obstructive Pulmonary Disease: Cardiovascular and Respiratory Outcomes
Characteristics and Outcomes of Patients with Heart Failure and History of Malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register
Iron Deficiency Definitions in Heart Failure Across Ejection Fraction Phenotypes
How to Tackle Therapeutic Inertia in Heart Failure with Reduced Ejection Fraction. A Scientific Statement of the Heart Failure Association of the ESC
Physician Perceptions, Attitudes, and Strategies Towards Implementing Guideline-Directed Medical Therapy in Heart Failure with Reduced Ejection Fraction. A Survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice
Trends in Heart Failure Mortality in Sweden Between 1997 and 2022
Status and Timing of Angiotensin Receptor–Neprilysin Inhibitor Implementation in Patients with Heart Failure and Reduced Ejection Fraction: Data from the Swedish Heart Failure Registry
Phenotyping Patients with Chronic Obstructive Pulmonary Disease and Heart Failure
Real-World Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Heart Failure and Reduced Ejection Fraction: Data from the Swedish Heart Failure Registry
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Iron Deficiency in Heart Failure: Screening, Prevalence, Incidence and Outcome Data from the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements Collaborative Project
Eligibility for Vericiguat in a Real-World Heart Failure Population According to Trial, Guideline and Label Criteria: Data from the Swedish Heart Failure Registry
Patient Profile and Outcomes Associated with Follow-Up in Specialty vs. Primary Care in Heart Failure